EP4392025A1 — Anti-fungals compounds targeting the synthesis of fungal sphingolipids
Assigned to Research Foundation of the State University of New York · Expires 2024-07-03 · 2y expired
What this patent protects
The present invention provides a compound having the structure: wherein R3, R4, R5, R6, and R7 are each independently, H, halogen, CN, -CF3, -OCF3, -NO2, alkyl, alkenyl, alkynyl, aryl, heteroaryl, heterocycle, -OH, -OAc, -OR13, -COR13, -CH2OR13, -SH, -SR13, -SO2R13, -NH2, -NHR13,…
USPTO Abstract
The present invention provides a compound having the structure: wherein R3, R4, R5, R6, and R7 are each independently, H, halogen, CN, -CF3, -OCF3, -NO2, alkyl, alkenyl, alkynyl, aryl, heteroaryl, heterocycle, -OH, -OAc, -OR13, -COR13, -CH2OR13, -SH, -SR13, -SO2R13, -NH2, -NHR13, - NR14R15, -NHCOR12, or -CONR14R15; R9, R10, R11, and R12 are each independently, H, CN, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, -OAc, -COR13, -SH, -SR13, -SO2R13, -NH2, -NHR13, -NR14R15, -NHCOR12, or -CONR14R15; wherein each occurrence of R13 is independently alkyl, alkenyl, alkynyl, aryl, or heteroaryl, wherein each occurrence of R14 is independently -H, alkyl, alkenyl, alkynyl, aryl, or heteroaryl, wherein each occurrence of R15 is independently -H, alkyl, alkenyl, alkynyl, aryl, or heteroaryl, wherein when R14 is methyl, R15 is not methyl; wherein at least one of R9, R10, R11, and R12 is not H; wherein at least one of R3, R4, R5, R6, and R7 is not H.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.